JP2024509316A5 - - Google Patents
Info
- Publication number
- JP2024509316A5 JP2024509316A5 JP2023555709A JP2023555709A JP2024509316A5 JP 2024509316 A5 JP2024509316 A5 JP 2024509316A5 JP 2023555709 A JP2023555709 A JP 2023555709A JP 2023555709 A JP2023555709 A JP 2023555709A JP 2024509316 A5 JP2024509316 A5 JP 2024509316A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleotide sequence
- vector
- identity
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2103470.7 | 2021-03-12 | ||
| GBPCT/GB2021/050633 | 2021-03-12 | ||
| PCT/GB2021/050633 WO2021181118A1 (en) | 2020-03-12 | 2021-03-12 | Gene therapy |
| GBGB2103470.7A GB202103470D0 (en) | 2021-03-12 | 2021-03-12 | Promoter |
| PCT/GB2021/051668 WO2022003357A1 (en) | 2020-06-30 | 2021-06-30 | Vector |
| GBPCT/GB2021/051668 | 2021-06-30 | ||
| PCT/GB2022/050649 WO2022189811A1 (en) | 2021-03-12 | 2022-03-14 | Minimal nephrin promoter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509316A JP2024509316A (ja) | 2024-02-29 |
| JP2024509316A5 true JP2024509316A5 (https=) | 2025-03-21 |
Family
ID=75623235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555709A Pending JP2024509316A (ja) | 2021-03-12 | 2022-03-14 | 最小ネフリンプロモーター |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20250283072A1 (https=) |
| EP (2) | EP4722371A2 (https=) |
| JP (1) | JP2024509316A (https=) |
| KR (1) | KR20230161459A (https=) |
| CN (1) | CN117377770A (https=) |
| AU (1) | AU2022235209A1 (https=) |
| BR (1) | BR112023018362A2 (https=) |
| CA (1) | CA3211566A1 (https=) |
| DK (1) | DK4305181T3 (https=) |
| ES (1) | ES3056304T3 (https=) |
| FI (1) | FI4305181T3 (https=) |
| GB (1) | GB202103470D0 (https=) |
| HR (1) | HRP20251561T1 (https=) |
| IL (1) | IL305714A (https=) |
| MX (1) | MX2023010573A (https=) |
| PL (1) | PL4305181T3 (https=) |
| PT (1) | PT4305181T (https=) |
| WO (1) | WO2022189811A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202003109D0 (en) * | 2020-03-04 | 2020-04-15 | Univ Bristol | Gene therapy |
| GB202003618D0 (en) | 2020-03-12 | 2020-04-29 | Univ Bristol | Gene Therapy |
| GB202217332D0 (en) * | 2022-11-18 | 2023-01-04 | Univ Bristol | Methods |
| EP4397976A1 (en) * | 2023-01-09 | 2024-07-10 | x-kidney diagnostics GmbH | Biomarkers for the pre-clinical and/or early-stage detection and/or diagnosis of kidney diseases |
| GB202309909D0 (en) * | 2023-06-29 | 2023-08-16 | Purespring Therapeutics Ltd | Regulatory elements |
| GB202309908D0 (en) * | 2023-06-29 | 2023-08-16 | Purespring Therapeutics Ltd | Polynucleotides, aav vectors, and pharmaceutical compositions for treating complement-mediated kidney diseases |
| GB202309913D0 (en) * | 2023-06-29 | 2023-08-16 | Purespring Therapeutics Ltd | Polynucleotides, avv vectors, and pharmaceutical compositions for treating nephrotic syndrome |
| GB202309914D0 (en) * | 2023-06-29 | 2023-08-16 | Purespring Therapeutics Ltd | Promoters |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT904392E (pt) | 1996-10-17 | 2001-06-29 | Oxford Biomedica Ltd | Vectores retrovirais |
| US8852936B2 (en) | 2012-09-21 | 2014-10-07 | Laurantis Pharma Oy | Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery |
| TW201506036A (zh) | 2013-08-14 | 2015-02-16 | Laurantis Pharma Oy | Vegf-c及ccbe1之治療用途 |
| GB201900702D0 (en) * | 2019-01-18 | 2019-03-06 | Univ Bristol | Therapy |
-
2021
- 2021-03-12 GB GBGB2103470.7A patent/GB202103470D0/en not_active Ceased
-
2022
- 2022-03-14 CA CA3211566A patent/CA3211566A1/en active Pending
- 2022-03-14 AU AU2022235209A patent/AU2022235209A1/en active Pending
- 2022-03-14 BR BR112023018362A patent/BR112023018362A2/pt unknown
- 2022-03-14 EP EP25181596.5A patent/EP4722371A2/en active Pending
- 2022-03-14 PT PT227107141T patent/PT4305181T/pt unknown
- 2022-03-14 EP EP22710714.1A patent/EP4305181B1/en active Active
- 2022-03-14 DK DK22710714.1T patent/DK4305181T3/da active
- 2022-03-14 FI FIEP22710714.1T patent/FI4305181T3/fi active
- 2022-03-14 US US18/280,699 patent/US20250283072A1/en active Pending
- 2022-03-14 JP JP2023555709A patent/JP2024509316A/ja active Pending
- 2022-03-14 PL PL22710714.1T patent/PL4305181T3/pl unknown
- 2022-03-14 ES ES22710714T patent/ES3056304T3/es active Active
- 2022-03-14 KR KR1020237034581A patent/KR20230161459A/ko active Pending
- 2022-03-14 WO PCT/GB2022/050649 patent/WO2022189811A1/en not_active Ceased
- 2022-03-14 IL IL305714A patent/IL305714A/en unknown
- 2022-03-14 MX MX2023010573A patent/MX2023010573A/es unknown
- 2022-03-14 CN CN202280034399.8A patent/CN117377770A/zh active Pending
- 2022-03-14 HR HRP20251561TT patent/HRP20251561T1/hr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024509316A5 (https=) | ||
| FI4305181T3 (fi) | Minimaalinen nefriinipromoottori | |
| ES2618851T3 (es) | Purificación de vectores retrovirales | |
| JP2022529631A5 (https=) | ||
| RU2014138491A (ru) | Композиции и способы лечения гемоглобинопатии | |
| AU2019350871B2 (en) | Methods and compositions for increasing protein expression and/or treating a haploinsufficiency disorder | |
| JP2024095717A5 (https=) | ||
| JP2024099770A5 (https=) | ||
| JP2020522269A5 (https=) | ||
| RU2019133002A (ru) | ЭКСПРЕССИОННЫЕ КАССЕТЫ MeCP2 | |
| HRP20241180T1 (hr) | Modificirani faktor ix, te pripravci, postupci i upotreba za prijenos gena u stanice, organe i tkiva | |
| JP2018522529A5 (https=) | ||
| JP2005502355A5 (https=) | ||
| JP2024523394A5 (https=) | ||
| CA2370103A1 (en) | Method and means for producing high titer, safe, recombinant lentivirus vectors | |
| JP5670330B2 (ja) | 最適化したプロモーター配列 | |
| JP2022530095A5 (https=) | ||
| JP2023551874A5 (https=) | ||
| JP2021536250A5 (https=) | ||
| JP2023545433A5 (https=) | ||
| US20210332344A1 (en) | Directed modification of rna | |
| JP2023551873A5 (https=) | ||
| CN116949012B (zh) | 一种融合蛋白及其应用 | |
| JP2023539631A5 (https=) | ||
| JP2023534293A5 (https=) |